Showing results (11-20 of 207) with videos related to
Sort By:
Pageof 21
The Journal of Clinical Psychiatry|March 7, 2009
New understanding of mechanisms of action of bipolar medicationsGerard SanacoraProceedings of the National Academy of Sciences of the United States of America|November 27, 2023
Ketamine and the neurobiology of depression: Toward next-generation rapid-acting antidepressant treatmentsJohn H Krystal, Alfred P Kaye, Sarah Jefferson, et al.Focus (American Psychiatric Publishing)|January 25, 2020
Ketamine: A Review for CliniciansGerard Sanacora, Rachel KatzPharmacology, Biochemistry, and Behavior|November 24, 2011
The roles of glutamate receptors across major neurological and psychiatric disordersSteve Siegel, Gerard SanacoraCNS Drugs|September 7, 2021
Evaluating the Role of Ketamine/Esketamine in the Management of Major Depressive Disorder with Suicide RiskSina Nikayin, Gerard SanacoraCNS Spectrums|January 10, 2006
Beyond monoamines: glutamatergic function in mood disordersAkira Kugaya, Gerard SanacoraThe Mount Sinai Journal of Medicine, New York|August 16, 2008
Major depression: emerging therapeuticsSrijan Sen, Gerard SanacoraCNS & Neurological Disorders Drug Targets|April 14, 2007
GABAergic contributions to the pathophysiology of depression and the mechanism of antidepressant actionGerard Sanacora, Aybala SaricicekBiological Psychiatry|June 4, 2013
From pathophysiology to novel antidepressant drugs: glial contributions to the pathology and treatment of mood disordersGerard Sanacora, Mounira BanasrNeuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 27, 2014
Ketamine: promising path or false prophecy in the development of novel therapeutics for mood disorders?Gerard Sanacora, Alan F SchatzbergPageof 21